Published in Obesity and Diabetes Week, January 31st, 2005
Revenues are expected to be in the range of $7.7 million to $7.8 million versus original guidance of $6.0 million to $6.6 million, excluding any effect from the Slim and Tone acquisition on December 2, 2004.
Commenting on the preliminary results for the quarter, Chairman and Chief Executive Officer Mike Hagan noted, "The year ended strongly. Year-over-year, revenue grew by about 85% for the fourth quarter and about 68% for the year....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.